Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/45328


Becton-Dickinson Medical Device Company Intelligence Report


Description: Becton, Dickinson and Company (BD) is engaged principally in the manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, industry and the general public. Its operations consist of three worldwide business segments: BD Medical, BD Diagnostics and BD Biosciences.

BD Medical produces a portfolio of medical devices that are used in a wide range of healthcare settings. They include safety-engineered injection, infusion and surgery products. BD Medical’s principal product lines include needles, syringes and intravenous (IV) catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self injection of insulin and other drugs used in the treatment of diabetes; prefillable drug delivery devices provided to pharmaceutical companies and sold to end-users as drug/device combinations; regional anaesthesia needles and trays; sharps disposal containers; and home healthcare products. The primary markets served by BD Medical are hospitals and clinics; physicians’ office practices; consumers and retail pharmacies; public health agencies; pharmaceutical companies; and healthcare workers.

BD Diagnostics provides products for the collection and transport of diagnostic specimens and instrumentation for analysis across a broad range of infectious disease testing, including healthcare-associated infections (HAIs). BD Diagnostics’ principal products and services include integrated systems for specimen collection; safety-engineered collection products and systems; plated media; automated blood culturing systems; molecular testing systems for sexually-transmitted diseases and HAIs; micro-organism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screenings; and rapid diagnostic assays. BD Diagnostics serves hospitals, laboratories and clinics; reference laboratories; blood banks; healthcare workers; patients; physicians’ office practices; and industrial microbiology laboratories.

BD Biosciences produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. That information is used to aid the discovery and development of new drugs and vaccines, and to improve the diagnosis and management of diseases. BD Biosciences’ principal product lines include fluorescence activated cell sorters and analysers; cell imaging systems, monoclonal antibodies and kits for performing cell analysis; reagent systems for life sciences research; tools to aid in drug discovery and growth of tissue and cells; cell culture media supplements for biopharmaceutical manufacturing; and diagnostic assays. The primary markets served by BD Biosciences are research and clinical laboratories; hospitals and transplant centres; blood banks; and biotechnology and pharmaceutical companies.
BD’s products are manufactured and sold worldwide. The company has manufacturing operations outside the US in Brazil, Canada, China, France, Germany, Hungary, India, Ireland, Japan, Mexico, Pakistan, Singapore, South Korea, Spain, Sweden and the UK.

In the fiscal year ended 30th September 2010, BD generated net earnings of US$1.32 billion on revenues of US$7.37 billion. In the first six months of fiscal 2011 (ended 31st March 2011), the company produced earnings of US$628 million on revenues of US$3.76 billion. BD has a global workforce of approximately 28,800 employees.

This company report provides

Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format

Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location

Strategic Focus
Investigates the company’s aims and its areas of focus

Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?

Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities

Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded

Mergers, Acquisitions, Minority Investments and Divestments

Litigation

Key Corporate Events

The report was produced as part of Medical Device Companies Analysis (MDCA). For more information on MDCA, click here.


Contents: OVERVIEW

FINANCIAL REVIEW

First Half Fiscal 2011 Financial Results
- Medical
- Diagnostics
- Biosciences

Fiscal Year 2010 Financial Results
- Medical
- Diagnostics
- Biosciences Segment
- Five-Year Financial Data
- Outlook
- Employees

STRATEGIC FOCUS
- Medical
- Diagnostics
- Biosciences

PRODUCTS
- BD Medical
- Medical Surgical Products
- Safety-engineered Products
- Infusion Therapy
- Injection Therapy
- Sharps Disposal Systems
- Anaesthesia Products
- Pharmaceutical Systems
- Diabetes Care
- BD Medical – Planned Product Launches
- BD Diagnostics Products
- Preanalytical Systems
- Venous Blood Collection
- Capillary Blood Collection
- Urine Collection
- Molecular Diagnostics and Proteomics
- Diagnostic Systems
- BD Diagnostics – TriPath Products
- BD Diagnostics – Infectious Disease
- BD Diagnostics – Planned Product Launches

RESEARCH AND DEVELOPMENT
- Research Establishments
- R&D Expenditure
- Acquired In-Progress R&D
- Accuri Cytometers
- HandyLab
- R&D Projects
- Juvenile Diabetes Research Foundation
- Tyrian Diagnostics
- Accelr8 Technology

MANUFACTURING AND DISTRIBUTION
- Manufacturing
- Distribution

AGREEMENTS
- Diagenode
- Waste Management Healthcare Solutions
- Healthcare Plastics Recycling Council
- Catheter Flushing
- UCL Business
- Abaxis
- Lonza Group
- Bruker Daltonics
- Alverix
- PEPFAR
- Exigon
- Eurogentec
- Juvenile Diabetes Research Foundation
- Caliper Life Sciences
- HandyLab
- Fujirebio Diagnostics
- Luminex
- Wyeth Pharmaceuticals
- Sanofi Pasteur
- Greiner & Soehne
- Hindustan Latex
- Specialized Health Products International
- Luther Research Partners
- Sekunjalo Healthcare
- Alaris Medical Systems
- Antares Pharma
- MedImmune (Aviron)
- Baxter Healthcare
- NeurOptics

MERGERS AND ACQUISITIONS

- Accuri Cytometers
- Dynacon’s Lab Systems business
- HandyLab
- ICPA
- Cytopeia
- Plasso Technology
- TriPath Imaging
- GeneOhm Sciences
- Atto Bioscience
- Saf-T-Med
- Kendall’s Anaesthesia Product Line
- Biometric Imaging
- Transduction Laboratories/Glentech
- Luther Medical Products
- MDI Instruments
- Boin Medica
- Concepts in Healthcare
- Ohmeda’s Medical Device Division
- Tru-Fit Marketing Corporation
- IntelliCode Division of MedPlus
- Visitec
- Difco Laboratories and PharMingen


Summary: Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available.


Companies Mentioned - Atto Bioscience - Saf-T-Med - Kendall's Anaesthesia Product Line - Biometric Imaging - Transduction Laboratories/Glentech - Luther Medical Products - MDI Instruments - Boin Medica - Concepts in Healthcare - Ohmeda's Medical Devices Division - Tru-Fit Marketing Corporation - IntelliCode Division of MedPlus - Visitec - Difco Laboratories and PharMingen - Med-Safe Systems - Cell Analysis Systems - Hoffman-La Roche's Microbiology Business - BD/Medico - SyneCor - Lucent Medical Systems - Clontech - Vyteris - Vial Medical Infusion System - Hindustan Latex Ltd - Specialized Health Products International - Medtronic MiniMed - Eli Lilly - PDI Medical Devices & Diagnostics - Cell Robotics - AorTech International - Sekunjalo Healthcare - Omnicell.com - Chindex International - Med-Design - Alaris Medical Systems - Antares Pharma - Aviron - Baxter Healthcare - Premier - Novation - SureCare


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/45328

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 14/02/2012 06:54:54
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Becton-Dickinson Medical Device Company Intelligence Report
Web Address:
http://www.researchandmarkets.com/reports/45328
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (Online Access) - Enterprisewide €2,450.00
Electronic (Online Access) - Single User €370.00
Electronic (PDF) - Single User €370.00
Electronic (PDF) - Enterprisewide €2,450.00
Hard Copy €370.00 + EUR€ 50.00 Shipping/Handling *
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 14/02/2012 06:54:54

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)